Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In reply.
Duffner PK, Armstrong FD, Helton K, Brecher ML, Bell B, Chauvenet AR. Duffner PK, et al. Among authors: brecher ml. J Pediatr Hematol Oncol. 2014 Aug;36(6):501-2. doi: 10.1097/MPH.0000000000000145. J Pediatr Hematol Oncol. 2014. PMID: 24633298 No abstract available.
Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.
Duffner PK, Armstrong FD, Chen L, Helton KJ, Brecher ML, Bell B, Chauvenet AR. Duffner PK, et al. Among authors: brecher ml. J Pediatr Hematol Oncol. 2014 Jan;36(1):8-15. doi: 10.1097/MPH.0000000000000000. J Pediatr Hematol Oncol. 2014. PMID: 24345882 Free PMC article.
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group.
Brecher ML, Schwenn MR, Coppes MJ, Bowman WP, Link MP, Berard CW, Shuster JJ, Murphy SB. Brecher ML, et al. Med Pediatr Oncol. 1997 Dec;29(6):526-33. doi: 10.1002/(sici)1096-911x(199712)29:6<526::aid-mpo2>3.0.co;2-m. Med Pediatr Oncol. 1997. PMID: 9324339 Clinical Trial.
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA, Leventhal B, Brecher ML, Marcus RB, Cantor A, Gieser PW, Ternberg JL, Behm FG, Wharam MD Jr, Chauvenet AR. Weiner MA, et al. Among authors: brecher ml. J Clin Oncol. 1997 Aug;15(8):2769-79. doi: 10.1200/JCO.1997.15.8.2769. J Clin Oncol. 1997. PMID: 9256118 Clinical Trial.
High-dose cyclophosphamide-high-dose methotrexate with coordinated intrathecal therapy for advanced nonlymphoblastic lymphoma of childhood: results of a Pediatric Oncology Group study.
Sullivan MP, Brecher M, Ramirez I, Ragab A, Hvizdala E, Pullen J, Shuster J, Berard C, Crist W, Vietti T. Sullivan MP, et al. Am J Pediatr Hematol Oncol. 1991 Fall;13(3):288-95. doi: 10.1097/00043426-199123000-00007. Am J Pediatr Hematol Oncol. 1991. PMID: 1793154 Clinical Trial.
Recombinant interferon alfa given before and in combination with standard chemotherapy in children with acute lymphoblastic leukemia in first marrow relapse: a Pediatric Oncology Group pilot study.
Ochs J, Brecher ML, Mahoney D, Vega R, Pollock BH, Buchanan GR, Whitehead VM, Ravindranath Y, Freeman AI. Ochs J, et al. Among authors: brecher ml. J Clin Oncol. 1991 May;9(5):777-82. doi: 10.1200/JCO.1991.9.5.777. J Clin Oncol. 1991. PMID: 2016619 Clinical Trial.
105 results